new glp 1 agonist GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Frontiers | GLP−1 receptor agonists
Description
GLP-1 Agonists Show Promise in Treating Substance Use Disorders Nov 7, 2025 5 min read Updated: Dec 17, 2025 In recent years, medications originally developed to treat Type 2 diabetes, obesity, and other weight-related conditionssuch as semaglutide and liraglutideare showing promise in treating substance use disorders (SUDs)
Other New Stuff: The Genetics of G-Agonists In a seminal study of the genomics of glucose regulation in nearly 500,000 people, specific coding variants of the GLP-1 receptor (GLP1R) were associated with potential GLP-1 drug response
Halpern, B
Both contain the same active ingredient and are used the same way, though the generic is typically more affordable, especially when combined with prescription discount coupons
GLP-1 agonists have been used as a treatment for type 2 diabetes for nearly two decades
10.1111/dom.14399 13 BuseJ
